Clinical updates, including trial initiations, enrollment status and data readouts and publications: 180, Aelis, Algernon, Ayala, Beam, Bioxytran, Geneuro, GSK, Humanetics, Horizon, Inhibrx, Midatech, Mineralys, Monopar, Oncosec, Sirona, Skye.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Geneseeq Technology, Nanovibronix, Pixcell Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alphyn, Antengene, Arcutis, Beckley Psytech, Daiichi Sankyo, Endevica, Enlivex, Excellthera, Innovent, Nanobiotix, Nouscom, Reistone, Vect-horus, Zyua.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Acelyrin, Affibody, Atom Bioscience, Bridge, Enanta, Inmagene, Novavax, Que Oncology, Resolve, Sirnaomics, Telix, Vaxxas.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Apexigen, Aptose, Ascendis, Assembly, Epiendo, Hutchmed, Infinity, Innovent, Intellia, Ionis, Kezar, Lindis, Lumos, Moderna, Mymd, Nervgen, Priothera, Sellas, Tallac, Viridian.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aimmune, Aura, UCB.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Enable Medicine, Endologix, Tandem Diabetes Care.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alpheus, Atom, Biosplice, Cybin, Equillium, Immix, Immunitybio, Inventprise, Janssen, Longeveron, Nanology, Oncosec, Que, Redx, Resolve, Stellas, TME, Unicycive.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Galvanize, Viz.ai.